Advertisement

European Archives of Oto-Rhino-Laryngology

, Volume 270, Issue 11, pp 2871–2874 | Cite as

Evaluation of hearing in patients with familial Mediterranean fever

  • Kerem Polat
  • İsmail Önder UysalEmail author
  • Soner Şenel
  • Cemil Güler
  • Kasım Durmuş
  • Suphi Müderris
Otology

Abstract

Familial Mediterranean fever (FMF) is a common and well-understood hereditary periodic fever syndrome. Hereditary periodic fever syndromes include a group of multisystem diseases characterized by recurrent fever attacks with inflammation affecting skin, joints, and some other tissues. These are FMF, tumor necrosis factor receptor, tumor necrosis factor receptor associated periodic syndrome, hyperimmunglobulinemia D syndrome, Muckle–Wells syndrome, and familial cold urticaria. In literature, it is determined that some of these diseases cause hearing loss. In light of the foregoing, we thought that FMF patients may have the same type of subclinical hearing loss and, therefore, the hearing ability of these patients was evaluated with otoacoustic emission and high frequency audiometry tests.

Keywords

Familial Mediterranean fever High frequency audiometry Otoacoustic emission Evaluation of hearing function 

Notes

Conflict of interest

We have no conflict of interest that we should disclose.

References

  1. 1.
    Öztürk A, Elbosky E, Elsayed SM, Alhodhod M, Akar N (2009) Mutational analysis of the MEFV gene in Egyptian patients with familial Mediterranean fever. Turk J Med Sci 39:229–234Google Scholar
  2. 2.
    Ben-Chetrit E, ve Levy M (1998) Familial Mediterranean fever. Lancet 351:659–664PubMedCrossRefGoogle Scholar
  3. 3.
    Drenth JPH, ve Van Der Meer JWH (2001) Hereditary periodic fever. N Engl J Med 345:1748–1756PubMedCrossRefGoogle Scholar
  4. 4.
    Kasapçopur Ö, ve Arısoy N (2006) Ailesel Akdeniz ateşi ve diğer otoenflamatuar hastalıklar. Türk Pediatri Arşivi 41:9–17Google Scholar
  5. 5.
    Glattke TJ, ve Robinette MS (2002) Otoacoustic emissions—clinical applications, 2nd ed. Chapter: Transient evoked otoacoustic emissions. Thieme, New York, p 95–115Google Scholar
  6. 6.
    Glattke TJ, ve Robinette MS (2002) Otoacoustic emissions—clinical applications, 2nd ed. Chapter: Distortion product otoacoustic emissions in relation to hearing loss, Thieme, New York, p 243–272Google Scholar
  7. 7.
    Kemp DT (1978) Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 64:1386–1391PubMedCrossRefGoogle Scholar
  8. 8.
    Dicroff HG (1982) Behavior of high frequency hearing in noise. Audiology 21:83–92CrossRefGoogle Scholar
  9. 9.
    Güngör N, Böke B, Belgin E, Tunçbilek E (2000) High frequency hearing loss in ullrich turner syndrome. Eur J Pediatr 159:740–744PubMedCrossRefGoogle Scholar
  10. 10.
    Jacobson EJ (1969) Clinical finding in high frequency treshold in ototoxic drug usage. J Aud Res 9:379–389Google Scholar
  11. 11.
    Stuchly MA (1998) Biomedical concerns in wireless communications. Crit Rev Biomed Eng 26:117–151PubMedCrossRefGoogle Scholar
  12. 12.
    Lidar M (2007) Livneh A familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med 65:318–324PubMedGoogle Scholar
  13. 13.
    Heller HS, ve Sherf L (1958) Familial Mediterranean fever (FMF). Arch Intern Med 102:50–71CrossRefGoogle Scholar
  14. 14.
    Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706–1712PubMedCrossRefGoogle Scholar
  15. 15.
    Mamou H, Cattan R (1952) La maladie periodique (sur 14 cas personnels dont 8 compliques de nephropathies). Sem Hop Paris 28:1062–1070PubMedGoogle Scholar
  16. 16.
    Turkish FMF study group (2005) Familial Mediterranean fever in Turkey: results of a nationwide study. Medicine 84:1–11CrossRefGoogle Scholar
  17. 17.
    Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC et al (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46:2445–2452PubMedCrossRefGoogle Scholar
  18. 18.
    Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA et al (1987) A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome: a specific entity analysed in 30 patients. Scand J Rheumatol Suppl 66:57–68PubMedCrossRefGoogle Scholar
  19. 19.
    Gorlin R, Toriel lo H, Cohen M (1995) Hereditary hearing loss and its syndromes. Oxford University Press, New YorkGoogle Scholar
  20. 20.
    Hawkins PN, Bybee A, Aganna E, McDermott MF (2004) Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease (NOMID). Arthritis Rheum 50:2708–2709PubMedCrossRefGoogle Scholar
  21. 21.
    Ahmadi N, Brewer CC, Zalewski C, King KA, Butman JA, Plass N et al (2011) Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestations. Otolaryngol Head Neck Surg 145:295–302PubMedCrossRefGoogle Scholar
  22. 22.
    Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M et al (2006) Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 54:1697–1700PubMedCrossRefGoogle Scholar
  23. 23.
    Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ et al (1990) Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336–340PubMedCrossRefGoogle Scholar
  24. 24.
    Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467–478PubMedCrossRefGoogle Scholar
  25. 25.
    Ichimiya I, Adams JC, Kimura RS (1994) Changes in immunostaining of cochleas with experimentally induced endolymphatic hydrops. Ann Otol Rhinol Laryngol. 103:457–468PubMedGoogle Scholar
  26. 26.
    Adams JC (2008) Clinical implications of inflammatory cytokins in the cochlea: a technical note. Otol Neurotol. 29:1043–1049CrossRefGoogle Scholar
  27. 27.
    Yoshida K, Ichimiya I, Suzuki M, Mogi G (1999) Effect of proinflammatory cytokines on cultured spiral ligament fibrocytes. Hear Res 137:155–159PubMedCrossRefGoogle Scholar
  28. 28.
    Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM (2003) Proinflammatory cytokine expression in the endolymphatic sac during iner ear inflammation. J Assoc Res Otolaryngol 4:139–147PubMedCrossRefGoogle Scholar
  29. 29.
    Hashimoto S, Billings P, Harris JP, Firestein GS, Keithley EM (2005) Innate immunity contributes to cochlear adaptive immune responses. Audiol Neurootol 10:35–43PubMedCrossRefGoogle Scholar
  30. 30.
    Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM (2002) Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope 112:1627–1634PubMedCrossRefGoogle Scholar
  31. 31.
    Hirose K, Discolo CM, Keasler JR, Ransohoff R (2005) Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma. J Comp Neurol 489:180–194PubMedCrossRefGoogle Scholar
  32. 32.
    Ichimiya I, Kurono Y, Hirano T, Mogi G (1998) Changes in immunostaining of inner ears after antigen challenge into the scala tympani. Laryngoscope 108:585–591PubMedCrossRefGoogle Scholar
  33. 33.
    Ichimiya I, Suzuki M, Hirano T, Mogi G (1999) The influence of pneumococcal otitis media on the cochlear lateral wall. Hear Res 131:128–134PubMedCrossRefGoogle Scholar
  34. 34.
    Wang X, Truong T, Billings PB, Harris JP, Keithley EM (2003) Block-age of immune-mediated inner ear damage by etanercept. Otol Neurotol 24:52–57PubMedCrossRefGoogle Scholar
  35. 35.
    Uysal İÖ, Gürbüzler L, Kaya A, Koç S, Gültürk S et al (2012) Evaluation of cochlear function using transient evoked otoacoustic emission in children with familial Mediterranean fever. Int J Pediatr Otorhinolaryngol 76:379–381PubMedCrossRefGoogle Scholar
  36. 36.
    Mansfield E, Chae JJ, Komarow HD, Brotz TM, Frucht DM et al (2001) The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 98:851–859PubMedCrossRefGoogle Scholar
  37. 37.
    Sukgi C, Pafitis I, Herer G (1999) Clinical applications of transiently evoked otoacoustic emissions in the pediatric population. Ann Otol Rhinol Laringol 108:132–137Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Kerem Polat
    • 1
  • İsmail Önder Uysal
    • 1
    Email author
  • Soner Şenel
    • 2
  • Cemil Güler
    • 3
  • Kasım Durmuş
    • 4
  • Suphi Müderris
    • 1
  1. 1.Department of OtolaryngologyCumhuriyet University Medical SchoolSivasTurkey
  2. 2.Department of Internal MedicineErciyes University Medical SchoolKayseriTurkey
  3. 3.Department of OtolaryngologyErzincan Mengücek Gazi Training and Research HospitalErzincanTurkey
  4. 4.Department of OtolaryngologySivas State HospitalSivasTurkey

Personalised recommendations